Open AccessJournal Article
Prevención y tratamiento de la hipertensión arterial sistémica en el paciente con enfermedad arterial coronaria
Celso Mendoza-González,Martín Rosas,Catalina Lomelí Estrada,José Antonio Lorenzo,Arturo Méndez,Jesús Martínez-Reding,Carlos Martínez-Sánchez,Gustavo Pastelín,Sergio Mario Férez-Santander,Fause Attie +9 more
TLDR
La asociacion entre hipertension arterial sistemica (HAS) y enfermedad arterial coronaria esta bien demostrada a traves de diversos estudios epidemiologicos.Abstract:
La asociacion entre hipertension arterial sistemica (HAS) y enfermedad arterial coronaria esta bien demostrada a traves de diversos estudios epidemiologicos. La hipertension arterial es un factor de riesgo independiente importante para el desarrollo de coronariopatia, enfermedad vascular cerebral y nefropatia. Existen avances importantes en el conocimiento de factores neurohumorales y hemodinamicos que confluyen en la fisiopatologia de la hipertension y en el desarrollo de enfermedad coronaria que permiten establecer mejores estrategias no solo de tratamiento sino tambien de prevencion, con la finalidad de disminuir la mortalidad cardiovascular. El espectro de la cardiopatia aterosclerosa es amplio y las estrategias de tratamiento de la hipertension deben adecuarse a la forma de manifestacion de la enfermedad coronaria que se presente. El tratamiento de ambas condiciones requiere de lineamientos especificos de acuerdo a las condiciones del paciente y la forma de presentacion de cada una de estas patologiasread more
Citations
More filters
Journal ArticleDOI
Dogma disputed: Can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?
Effects of losartan and captopril on mortality and morbidity after acute myocardial infarction: The OPTIMAAL randomized trial.
K Dickstein,J Kjekshus +1 more
Journal ArticleDOI
Ejercicio físico con ritmo: intervención de enfermería para el control de la hipertensión arterial en un municipio del estado de México
Cleotilde García Reza,Patricia Belén Mondragón Sánchez,Matiana Morales del Pilar,Maria Elizabeth Medina Castro +3 more
TL;DR: Estudio casi experimental pre and postest sin grupo de control, cuyo objetivo fue analizar los beneficios de un programa de ejercicio fisico con ritmo en personas con hipertension arterial dirigido por enfermeria en un municipio del Estado de Mexico.
Journal Article
Comportamiento de la mortalidad por enfermedad renal crónica hipertensiva en la República Mexicana entre 1998-2009. Un problema creciente
TL;DR: This study aims to analyze the behavior of HRD mortality in Mexico between 1998 and 2009 and analyzes the specific rates by age and sex and standardized mortality ratio (SMR) by states and regions.
Journal ArticleDOI
Predictors of prolonged intensive care unit stay in patients undergoing coronary surgery
Kazim Ergunes,Levent Yilik,Ismail Yurekli,Ufuk Yetkin,Yuksel Besir,Nagahan Karahan,Serkan Yazman,Ali Gürbüz +7 more
TL;DR: The factors affecting the length of intensive care unit (ICU) stay in patients undergoing isolated on-pump coronary artery bypass (CABG) and effective factors on morbidity, mortality, and survival among patients with prolonged ICU stay were investigated.
References
More filters
Journal ArticleDOI
Immediate versus deferred beta-blockade following thrombolytic therapy in patients with acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) II-B Study.
Robert Roberts,William J. Rogers,Hiltrud S. Mueller,Costas T. Lambrew,Daniel J. Diver,Hugh C. Smith,James T. Willerson,Genell L. Knatterud,Sandra A. Forman,Eugene R. Passamani +9 more
TL;DR: In appropriate postinfarction patients, beta-blockers are safe when given early after thrombolytic therapy and are associated with decreased myocardial ischemia and reinfarction in the first week but offer no benefit over late administration in improving ventricular function or reducing mortality.
Journal ArticleDOI
Eplerenone Reduces Mortality 30 Days After Randomization Following Acute Myocardial Infarction in Patients With Left Ventricular Systolic Dysfunction and Heart Failure
Bertram Pitt,Harvey D. White,Jose C. Nicolau,Felipe Martinez,Mihai Gheorghiade,Michael Aschermann,Dirk J. van Veldhuisen,Faiez Zannad,Henry Krum,Robin Mukherjee,John Vincent +10 more
TL;DR: Eplerenone 25 mg/day significantly reduced all-cause mortality 30 days after randomization and should be administered in the hospital after AMI in addition to conventional therapy in patients with an LVEF < or =40% and signs of heart failure.
Journal ArticleDOI
Cardioselective beta‐blockers for chronic obstructive pulmonary disease
TL;DR: The available evidence suggests that cardioselective beta-blockers, given to patients with COPD do not produce a significant short-term reduction in airway function or in the incidence of COPD exacerbations.
Journal ArticleDOI
Relationship of blood pressure to 25-year mortality due to coronary heart disease, cardiovascular diseases, and all causes in young adult men: the Chicago Heart Association Detection Project in Industry.
Katsuyuki Miura,Martha L. Daviglus,Alan R. Dyer,Kiang Liu,Daniel B. Garside,Jeremiah Stamler,Philip Greenland +6 more
TL;DR: In young adult men, BP above normal was significantly related to increased long-term mortality due to CHD, CVD, and all causes, and population-wide primary prevention, early detection, and control of higher BP are indicated from young adulthood on.
Journal ArticleDOI
Treatment of Hypertension in Adults With Diabetes
TL;DR: Health care providers who care for diabetic patients are advised to deal with, in addition to blood glucose levels, other comorbidities, such has hypertension, dyslipidemia, and coronary artery disease, which occur so frequently in patients.